Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Dec. 31, 2020

Prior Period Adjustment [Abstract]

Summary of Restatement of Financial Statements

The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the period, indicated:

	As Previously Reported			Adjustment			As Restated
Balance Sheet at February 13, 2020
Warrant Liability	$	—		$	28,806,800		$	28,806,800
Class A ordinary shares subject to possible redemption		262,859,036			(28,806,800	)		234,052,236
Class A ordinary shares		131			288			419
Additional paid-in capital		5,024,174			3,973,967			8,998,141
Accumulated deficit	$	(24,990	)	$	(3,974,255	)	$	(3,999,245	)
	As Previously Reported			Adjustment			As Restated
Selected Balance Sheet Items at March 31, 2020
Warrant Liability	$	—		$	17,557,600		$	17,557,600
Class A ordinary shares subject to possible redemption,		264,535,214			(17,557,596	)		246,977,618
Class A ordinary shares		115			175			290
Additional paid-in capital		3,308,081			(7,272,469	)		(3,964,388	)
Accumulated deficit	$	1,691,119		$	7,272,290		$	8,963,409
Selected Condensed Statement of Operations Items for Three Months Ended March 31, 2020
Warrants issuance costs	$	—			(1,044,453	)		(1,044,453	)
Excess of the fair value of private placement warrants over the cash received		—			(2,932,800	)		(2,932,800	)
Unrealized loss on change in fair value of warrants		—			11,249,200			11,249,200
Net income (loss)	$	1,714,085		$	7,272,290		$	8,986,375
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		6,900,000			(425,275	)		6,474,725
Basic and diluted net loss per ordinary share, Class B	$	(0.01	)		1.13			1.12

	As Previously Reported			Adjustment			As Restated
Selected Condensed Statement of Cash Flow Items for Three Months Ended March 31, 2020
Cash Flows from Operating Activities:
Net income (loss)	$	1,714,085		$	7,272,290		$	8,986,375
Excess of the fair value of private placement warrants over the cash received		—			2,932,800			2,932,800
Warrant issuance costs		—			1,044,110			1,044,110
Unrealized gain/loss on fair value changes of warrants	$	—		$	(11,249,200	)	$	(11,249,200	)
	As Previously Reported			Adjustment			As Restated
Selected Balance Sheet Items at June 30, 2020
Warrant Liability	$	—		$	16,014,800		$	16,014,800
Class A ordinary shares subject to possible redemption,		264,434,096			(16,014,800	)		248,419,296
Class A ordinary shares		116			160			276
Additional paid-in capital		3,404,038			(8,814,907	)		(5,410,869	)
Accumulated deficit	$	1,595,157		$	8,814,747		$	10,409,904
Selected Condensed Statement of Operations Items for Six Months Ended June 30, 2020
Warrants issuance costs	$	—			(1,044,453	)		(1,044,453	)
Excess of the fair value of private placement warrants over the cash received		—			(2,932,800	)		(2,932,800	)
Unrealized loss on change in fair value of warrants		—			12,792,000			12,792,000
Net income (loss)	$	1,618,123		$	8,814,747		$	10,432,870
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		6,900,000			(212,637	)		6,687,363
Basic and diluted net loss per ordinary share, Class B	$	(0.03	)		1.32			1.29
Selected Condensed Statement of Cash Flow Items for Six Months Ended June 30, 2020
Cash Flows from Operating Activities:
Net income (loss)	$	1,618,123		$	8,814,747		$	10,432,870
Excess of the fair value of private placement warrants over the cash received		—			2,932,800			2,932,800
Warrant issuance costs		—			1,044,453			1,044,453
Unrealized gain (loss) on fair value changes of warrants	$	—		$	(12,792,000	)	$	(12,792,000	)

	As Previously Reported			Adjustment			As Restated
Selected Balance Sheet Items at September 30, 2020
Warrant Liability	$	—		$	27,101,200		$	27,101,200
Class A ordinary shares subject to possible redemption,		264,272,806			(27,101,199	)		237,171,607
Class A ordinary shares		118			270			388
Additional paid-in capital		3,565,326			2,271,382			5,836,708
Accumulated deficit	$	1,433,868		$	(2,271,653	)	$	(837,785	)
Selected Condensed Statement of Operations Items for Nine Months Ended September 30, 2020
Warrants issuance costs	$	—			(1,044,453	)		(1,044,453	)
Excess of the fair value of private placement warrants over the cash received		—			(2,932,800	)		(2,932,800	)
Unrealized loss on change in fair value of warrants		—			1,705,600			1,705,600
Net income (loss)	$	1,456,834		$	(2,271,653	)	$	(814,819	)
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		6,900,000			(141,241	)		6,758,759
Basic and diluted net loss per ordinary share, Class B	$	(0.06	)		(0.33	)		(0.39	)
Selected Condensed Statement of Cash Flows Items for Nine Months Ended September 30, 2020
Cash Flows from Operating Activities:
Net income (loss)	$	1,456,834		$	(2,271,653	)	$	(814,819	)
Excess of the fair value of private placement warrants over the cash received		—			2,932,800			2,932,800
Warrant issuance costs		—			1,044,453			1,044,453
Unrealized gain (loss) on fair value changes of warrants	$	—		$	(1,705,600	)	$	(1,705,600	)